UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 23, 2002
----------------
PROXYMED, INC.
--------------
(Exact name of registrant as specified in its charter)
Florida 0-22052 65-0202059
------- ------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2555 Davie Road, Suite 110, Ft. Lauderdale, Florida 33317-7424
--------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (954) 473-1001
-------------
Item 9. Regulation FD Disclosure.
On October 24, 2002 at 10 a.m EDT, ProxyMed, Inc. (the "Company") will
hold a teleconference call to report its financial and operating results for the
quarter ended September 30, 2002. Information that will be presented in the call
is attached. Additionally, the Company's press release dated October 23, 2002
reporting financial results for the three and nine months ended September 30,
2002 is also attached.
FORWARD LOOKING STATEMENTS - This document contains forward-looking
statements that reflect the Company's current assumptions and expectations
regarding future events. While these statements reflect the Company's current
judgment, they are subject to risks and uncertainties. Actual results may differ
significantly from projected results due to a number of factors, including, but
not limited to the soundness of our business strategies relative to the
perceived market opportunities; our ability to successfully identify and
integrate acquisition candidates; our ability to successfully develop, market,
sell, cross-sell, install and upgrade our clinical and financial transaction
services and applications to current and new physicians, payers, medical
laboratories and pharmacies; our ability to consummate and integrate any
acquisitions successfully; our ability to compete effectively on price and
support services; our assessment of the healthcare industry's need, desire and
ability to become technology efficient; and our ability and that of our business
associates to comply with various government rules regarding healthcare and
patient privacy. These and other risk factors are more fully discussed in the
Risk Factor disclosure in our Form 10-K for the year ended December 31, 2001 and
our other filings with the Securities and Exchange Commission, which we strongly
urge you to read. ProxyMed expressly disclaims any intent or obligation to
update any forward-looking statements. When used, the words "believes,"
"estimated," "expects," "anticipates," "may" and similar expressions are
intended to identify forward-looking statements.
Item 7. Financial Statements and Exhibits.
(c) The following exhibits are included herein:
Exhibit 99.1 Information to be presented in third quarter 2002
financial results teleconference call to be held
on October 24, 2002.
Exhibit 99.2 Press Release dated October 23, 2002 reporting
financial results for the three and nine months
ended September 30, 2002.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ProxyMed, Inc.
Date: October 24, 2002 /s/ Judson E. Schmid
---------------- --------------------
Judson E. Schmid, Executive Vice
President and Chief Financial Officer
3
INDEX TO EXHIBITS
EXHIBIT NUMBER DESCRIPTION
99.1 Information to be presented in third quarter
2002 financial results teleconference call to
be held on October 24, 2002
99.2 Press Release dated October 23, 2002 reporting
financial results for the three and nine
months ended September 30, 2002.